project id: TCGA-HNSC; case submitter id: TCGA-D6-A6EP; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.26; rna integrity number: 7.1; age at index: 62; days to birth: -22674; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22674; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage III; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 424.0; icd 10 code: C13.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Hypopharynx, NOS; synchronous malignancy: No; tissue or organ of origin: Hypopharynx, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: No; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; years smoked: 43.0; is ffpe: false; composition: Not Reported; days to collection: 107; days to sample procurement: 0; initial weight: 300.0; portion submitter id: TCGA-D6-A6EP-01A-11; percent lymphocyte infiltration: 7.0; percent monocyte infiltration: 0.0; percent necrosis: 3.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 97.0; percent tumor nuclei: 75.0;